Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Cv Sciences Inc (CVSI)

Cv Sciences Inc (CVSI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0310 -0.0008 (-2.52%) 04/11/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0310 unch (unch) 15:55 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.0291
Day High
0.0325
Open 0.0291
Previous Close 0.0318 0.0318
Volume 61,800 61,800
Avg Vol 132,615 132,615
Stochastic %K 49.64% 49.64%
Weighted Alpha -30.20 -30.20
5-Day Change +0.0008 (+2.65%) +0.0008 (+2.65%)
52-Week Range 0.0277 - 0.1015 0.0277 - 0.1015
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 5,729
  • Shares Outstanding, K 184,794
  • Annual Sales, $ 15,710 K
  • Annual Income, $ -2,390 K
  • EBIT $ -2 M
  • EBITDA $ -2 M
  • 60-Month Beta 0.53
  • Price/Sales 0.37
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings $0.00 on 03/27/25
  • Next Earnings Date 05/13/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0283 +9.54%
on 04/04/25
Period Open: 0.0330
0.0369 -15.99%
on 03/17/25
-0.0020 (-6.06%)
since 03/11/25
3-Month
0.0281 +10.32%
on 03/10/25
Period Open: 0.0332
0.0450 -31.11%
on 02/14/25
-0.0022 (-6.63%)
since 01/10/25
52-Week
0.0277 +11.91%
on 12/12/24
Period Open: 0.0345
0.1015 -69.46%
on 06/05/24
-0.0035 (-10.14%)
since 04/11/24

Most Recent Stories

More News
CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results

SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...

CVSI : 0.0310 (-2.52%)
CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods

The innovative product line offers a unique choice of plant-based, 100% natural alternatives to the foods everyone loves.

CVSI : 0.0310 (-2.52%)
CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025

SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 20, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0310 (-2.52%)
CV Sciences Unveils New Aura Collection THC Fizz Tablets

The innovative, lemon-flavored fast-acting tablets provide a quick, uplifting experience, perfect for enhancing social moments or relaxing at home.

CVSI : 0.0310 (-2.52%)
CV Sciences, Inc. Launches Reserve Sleep Gummies

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0310 (-2.52%)
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0310 (-2.52%)
CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0310 (-2.52%)
CV Sciences, Inc. Reports First Quarter 2023 Financial Results

/PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in...

CVSI : 0.0310 (-2.52%)
CV Sciences, Inc. Introduces New THC Offering

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0310 (-2.52%)
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0310 (-2.52%)

Business Summary

CV Sciences Inc. is a life science company. Its operating segment consists of specialty pharmaceuticals and consumer products. Specialty pharma business segment is focused on developing and commercializing therapeutics utilizing synthetic Cannabidiol across several therapeutic areas. Consumer product...

See More

Key Turning Points

3rd Resistance Point 0.0360
2nd Resistance Point 0.0343
1st Resistance Point 0.0326
Last Price 0.0310
1st Support Level 0.0292
2nd Support Level 0.0275
3rd Support Level 0.0258

See More

52-Week High 0.1015
Fibonacci 61.8% 0.0733
Fibonacci 50% 0.0646
Fibonacci 38.2% 0.0559
Last Price 0.0310
52-Week Low 0.0277

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar